Eikon Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Eikon Therapeutics stock has a consensus rating of "Buy" and an average price target of $25.2. The average 1-year stock price forecast is 114.29% higher than the current stock price, while the lowest is $5.00 (-57.48%) and the highest is $34 (+189.12%).

Price Target: $25.2 (+114.29%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.00	$25.2	$29	$34
Change	-57.48%	+114.29%	+146.60%	+189.12%

Analyst Ratings

The average analyst rating for Eikon Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '26	Apr '26	May '26
Strong Buy	1	1	1
Buy	4	4	4
Hold	0	0	0
Sell	1	1	1
Strong Sell	0	0	0
Total	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Driscoll Wedbush	Wedbush	Sell Maintains $7 → $5	Sell	Maintains	$7 → $5	-57.48%	May 12, 2026
Robert Driscoll Wedbush	Wedbush	Sell Reiterates $7	Sell	Reiterates	$7	-40.48%	Mar 31, 2026
Imogen Mansfield Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 2, 2026
Brian Cheng JP Morgan	JP Morgan	Buy Initiates $29	Buy	Initiates	$29	+146.60%	Mar 2, 2026
Jason Zemansky B of A Securities	B of A Securities	Strong Buy Initiates $34	Strong Buy	Initiates	$34	+189.12%	Mar 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-6.74

from -115.29

EPS Next Year

-6.25

from -6.74

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	-	-	-	25.57M
Revenue Growth	-	-	-	-	-	-	-
EPS	-119.43	-96.76	-115.29	-6.74	-6.25	-6.13	-4.65
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	8	7	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-6.27	-5.08
Avg	-6.74	-6.25
Low	-7.28	-6.64

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.